13.600
+0,00%
2026-10-19
Fundamental Analysis
50 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +17.5% | +417.5% | 3 / 3 | +9.1% | +4.67 pp | +0.53 pp | +13.8% | 1.04 | 7.41 | 3.952 | +9,1% | 195 | +22,2% | 7.41 | 5.79 | +28,0% |
| Pts | 0 | 12 | 12 | 0 | 12 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 13.600 (close price on 2026-10-19)EPS (TTM): 1.835
Financial charts
1.Revenue & growth
VND bn1.849Q2/26
1.Revenue & growth
VND bn1.849Q2/26
2.Profit & growth
VND bn200Q2/26
3.Profit mix (Penman)
VND bn831Q2/26
4.Margins & cost structure
%14.5%Q2/26
5.Returns & cash cycle
% · days10.1%Q2/26
6.Earnings quality & cash
VND bn-1.233Q2/26
7.Asset structure
VND bn12.946Q2/26
8.Funding & debt health
VND bn · times12.946Q2/26
9.Revenue backlog
VND bn420Q2/26
10.Valuation
times · %7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %498Q2/26
Adjusted EPS growth, latest quarter
28.4%
Average adjusted EPS growth, 3 quarters
552%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26